Delivery Order SPE2DB22D3301-SPE2DB25FX8XU

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary contracting vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Trulicity (1.5 mg/0.5 ml pen) with a ceiling value of $3,937.94. The award is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The $1,161.12 firm fixed-price contract has an ultimate completion date of April 20, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,501.50, is for the Trulicity 3 mg/0.5 ml pen 0.5 ml medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $4,618.97 and runs through January 14, 2025. This award is associated with a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and in effect through November 2026. The IDC serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 17, 2025. The $1,049.07 delivery order is for the supply of Trulicity 0.75 mg/0.5 ml medication pens. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the DLA to procure a wide range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract has a firm fixed price of $3,967.20 and a completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for the medication Trulicity 1.5 mg/0.5 ml pen with a ceiling value of $2,612.52 and a completion date of May 30, 2023. The contract is a firm fixed-price arrangement. There is no set-aside designation mentioned, indicating open competition. This contract...
This is a $8,714.79 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is under DLA's Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 IDC that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for the medication Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 4.5 mg/0.5 ml pens. The $2,163.84 firm fixed-price contract has a completion date of December 30, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. The...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8XU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,227.17. The order is for the medication Trulicity 1.5 mg/0.5 ml pen with a completion date of January 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 4/24/25, 10:00 AM